I wouldn't buy this one at all. EXEL was a M* fav, surprising failure.
The only downside to the experience are the kids of the overly indulgent parents that let their kids run wild in the store. Some of them need a good crack on the head.
This is why Repsol walked away.
CHOP will be taken to the wood shed after September 15th if it can not get above $1.00. It has to trade above $1.00 for ten days or off to the pink sheets (and oblivion) for this one.
I know Craig, who is now board head and not president, did not think there was much of a future in battery powered cars. They did minimum work in this area, mostly for PR (driving a battery powered car to Quebec, etc.) and have not put a lot into this area. I assume the new president has similar feelings.
AZN market cap of 92.2 billion, GSK market cap of 115 billion. The GSK thing makes sense, as they want to merge with someone. Is the added amount too much for PFE?
I think most know that Sprint's coverage is spotty at best and the price is not a consideration. People switch to Sprint and then switch back when they realize how bad the service is.
because of their over use of debt, but am coming around, as it seems that Fredriksen is able to make deals that the others, his competitors, are not able to make.
your post is misleading in that DBank did not reiterate anything. They lowered their PT on SPLK to $55 from $65 and then went on to say that they preferred Tableau over SPLK, that SPLK looked exhausted, but still expensive.
support at all.
have learned by the failures of BIG, SPLS, and WMT in Canada and stayed away.